VKTX Stock Analysis: Buy, Sell, or Hold?
VKTX - Viking Therapeutics, Inc
$38.71
1.27 (3.39%)
▲
5d:
+1.76%
30d:
+31.98%
90d:
+11.24%
BUY
MODERATE Confidence
Analysis Updated: Jul 6, 2026 12:00 AM ET
Earnings: Jul 22, 2026
14d
Smart Money Distribution
None View Scanner →
Strength: 7.7/10
Get Alerted When VKTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
5 traders called VKTX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VKTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: VKTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: VKTX is currently trading at $38.71, which is considered extended relative to its 30-day fair value range of $28.68 to $36.61.
Technical Outlook: Technically, VKTX is showing sideways momentum. Immediate support is located at $30.52, while resistance sits at $41.40. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: VKTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $92.58 (+139.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VKTX is showing sideways momentum. Immediate support is located at $30.52, while resistance sits at $41.40. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: VKTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $92.58 (+139.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$28.68 -
$36.61
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range (+5.7% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.4%)
- BULLISH: Trading 139.2% below Wall St target ($92.58)
Trading Range Analysis
30-Day Trading Range
$28.68 -
$36.61
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$30.52
Resistance Level
$41.40
Current Trend
Sideways
Technical data as of
Jul 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.48
Wall Street Target
$92.58
(+139.2%)
Share & Embed Analysis
Last updated: July 07, 2026 4:41 AM ET
Data refreshes hourly during market hours. Next update: 5:41 AM
Data refreshes hourly during market hours. Next update: 5:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VKTX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Neil William Aubuchon
BUY
4475 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$435 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 62 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 56 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 56 HOLD |
